Issuers

 PT. Bank KB Bukopin Tbk

Issuer Code 

  BBKP

Number of Shares Offered 

  119,999,999,692 shares

Ratio (existing shares : new shares)

   100,000,000 : 176,762,922

Nominal Value 

  Rp 100 per share

Exercise Price 

  Rp 150

Dilution (if shareholders don't exercise their rights)   

63.87%

Use of Proceeds

-The capital injection that the company will undertake in KBBS has been disclosed in the Capital Injection Plan published on page 37 and the Projections of Financial Position (Balance Sheet) in the Annex on page 6 of the Adjustment Report of KBBS Business Plan for the years 2023-2025, submitted by KBBS based on Letter No. 164/BIS/III/2023 dated March 13, 2023, regarding Submission of Adjustment to Business Plan of Bank for the years 2023-2025. In the Adjustment to KBBS Business Plan for the years 2023-2025, it was previously disclosed that KBBS would conduct a capital increase through a rights issue to strategic investors.

- However, the capital increase will be carried out through a rights issue to the Company, not to strategic investors.

- The capital injection that the Company will undertake in KBBF has been disclosed in the Capital Adjustment Plan published on page 32 of the Adjustment Report of KBBF Business Plan for the years 2023-2025, submitted by KBBF based on Letter No. 087/DIRUT-BUFIN/III/2023 dated March 17, 2023, regarding Submission of Adjustment to Business Plan for the year 2023 of PT KB Bukopin Finance. KBBS and KBBF have not yet obtained approval from their respective industry supervisors regarding the Company's capital injection plan into these respective Subsidiaries. Furthermore, the process of increasing capital in the Subsidiaries, including the request for approval from the respective industry supervisors of the Subsidiaries, will be carried out after the Company obtains funds from PUT VII. The requirements that the company, KBBS, and KBBF must meet to obtain approval from the industry supervisors for the planned capital injection by the company into the Subsidiaries.

Date of Extraordinary General Meeting of Shareholders (RUPSLB) 

  November 30, 2022

Effective Date 

  May 5, 2023

Cum Date in the Regular and Negotiation Market 

  May 15, 2023

Ex Date in the Regular and Negotiation Market 

  May 16, 2023

Cum Date in the Cash Market

   May 17, 2023

Ex Date in the Cash Market 

  May 19, 2023

Recording Date 

  May 17, 2023

Distribution Date  

 May 12, 2023

Listing Date on the Exchange 

  May 22, 2023

Trading and Implementation Period of HMETD 

  May 22-26, 2023

Distribution Period of Shares Resulting from HMETD

    May 24-30, 2023

Last Date for Payment of Additional Subscription for Shares 

  May 30, 2023

Allocation Date  

 May 31, 2023

Refund for Additional Subscription of Shares 

  June 6, 2023